Top

Sports Medicine

Published in:

01-11-2010 | Review Article

Sport Psychiatry

A Systematic Review of Diagnosis and Medical Treatment of Mental Illness in Athletes

Authors: Dr Claudia L. Reardon, Robert M. Factor

Published in: Sports Medicine | Issue 11/2010

Abstract

Sport psychiatry focuses on diagnosis and treatment of psychiatric illness in athletes in addition to utilization of psychological approaches to enhance performance. As this field and its research base are relatively new, clinicians often deliver psychiatric care to athletes without a full understanding of the diagnostic and therapeutic issues unique to this population. In this systematic review, we discuss published findings relating to psychiatric diagnosis and medical treatment of mental illness in athletes.

There have been several studies looking at the prevalence of some psychiatric disorders in various athlete populations. Eating disorders and substance abuse are the most studied of these disorders and appear to be common problems in athletes. However, to provide informed understanding and treatment, we especially need more research on overtraining syndrome, bipolar disorder, suicidality, anxiety disorders, attention-deficit hyperactivity disorder (ADHD) and psychosis in athletes. Research is needed in the areas of prevalence, risk factors, prognosis and the unique experiences facing athletes with any of these disorders.

Additionally, there have not been any large, systematic studies on the use of psychotropic medications in athletes. Small studies suggest that some medications may either be performance enhancing or detrimental to performance, but we need larger studies with rigorous methodology. Higher level athletes suffering from psychiatric symptoms often have reservations about taking medications with unknown performance and safety effects, and methodological issues with the current literature database preclude any definitive conclusions on performance effects of psychiatric medications. We need many more, higher quality studies on the use by athletes of antidepressants, mood stabilizers, anxiolytics, stimulants and other ADHD medications, sedative-hypnotics and antipsychotics. Such studies should utilize sensitive performance measures and involve longer term use of psychotropic medications. Furthermore, study subjects should include athletes who actually have the psychiatric disorder for which the medication is proposed, and should include more women.

Begel D. Family systems-based treatment of the athlete family. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 206–28

Glick ID, Kamm R, Morse E. The evolution of sport psychiatry, circa 2009. Sports Med 2009; 39 (8): 607–13PubMed

Hellstedt J. Invisible players: a family systems model. Clin Sports Med 2005; 24 (4): 899–928PubMed

McDuff DR, Morse ED, White RK. Professional and collegiate team assistance programs: services and utilizationpatterns. Clin Sports Med 2005; 24 (4): 943–58PubMed

Kamm RL. The sport psychiatry examination. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 159–90

Glick ID, Horsfall JL. Diagnosis and psychiatric treatment of athletes. Clin Sports Med 2005; 24 (4): 771–81PubMed

Baum AL. Sport psychiatry: how to keep athletes in the game of life, on or off the field. Curr Psychiatry 2003; 2 (1): 51–6

Baum AL. Psychopharmacology in athletes. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 249–59

Burton RW. Mental illness in athletes. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WWNorton & Company, Inc., 2000: 61–81

10.

Oler MJ, Mainous AG, Martin CA, et al. Depression, suicidal ideation, and substance use among adolescents: areathletes at less risk? Arch Fam Med 1994; 3: 781–3PubMed

11.

Yang J, Peek-Asa C, Corlette JD, et al. Prevalence of and risk factors associated with symptoms of depression incompetitive collegiate student athletes. Clin J Sport Med 2007; 17 (6): 481–7PubMed

12.

Puffer JC, McShane JM. Depression and chronic fatigue in the college student-athlete. Prim Care 1991; 18 (2): 297–308PubMed

13.

Donohue B, Covassin T, Lancer K. Examination of psychiatric symptoms in student athletes. J Gen Psychol 2004; 131: 29–36PubMed

14.

Rosen LW, Smokler C, Carrier D, et al. Seasonal mood disturbances in collegiate hockey players. J Athl Train 1996; 31 (3): 225–8PubMed

15.

Kasper S, Rogers SLB, Yancey A, et al. Phototherapy in individuals with and without subsyndromal seasonal affectivedisorder. Arch Gen Psychiatry 1989; 46: 837–44PubMed

16.

Macleod AD. Sport psychiatry. Aust N Z J Psychiatry 1998; 32: 860–6PubMed

17.

Armstrong LE, VanHeest JL. The unknown mechanism of the overtraining syndrome: clues from depression andpsychoneuroimmunology. Sports Med 2002; 32: 185–209PubMed

18.

Morgan WP, Brown DR, Raglin JS, et al. Psychological monitoring of overtraining and staleness. Br J Sports Med 1987; 21 (3): 107–14PubMed

19.

Schwenk TL. The stigmatization and denial of mental illness in athletes. Br J Sports Med 2000; 34 (1): 4–5PubMed

20.

McCann S. Overtraining and burnout. In: Murphy SM, editor. Sport psychology interventions. Champaign (IL): Human Kinetics, 1995: 347–65

21.

Callister R, Callister RK, Fleck SJ, et al. Physiological and performance responses to overtraining in elite judo athletes. Med Sci Sports Exerc 1989; 22: 816–24

22.

Costill DL, Flynn MG, Kirwin JP, et al. Effects of repeated days of intensified training on muscle glycogen andswimming performance. Med Sci Sports Exerc 1998; 20: 249–54

23.

Hackney AC, Pearman SN, Nowacki JM. Physiological profiles of overtrained and stale athletes: a review. Appl Sport Psychol 1990; 2: 21–33

24.

Parham WD. The intercollegiate athlete: a 1990s profile. Couns Psychol 1993; 21: 411–29

25.

Backmand H, Kaprio J, Kujala U, et al. Influence of physical activity on depression and anxiety of former eliteathletes. Int J Sports Med 2003; 24: 609–16PubMed

26.

Schwenk TL, Gorenflo DW, Dopp RR, et al. Depression and pain in retired professional football players. Med Sci Sports Exerc 2007; 39 (4): 599–605PubMed

27.

Baum AL. Suicide in athletes: a review and commentary. Clin Sports Med 2005; 24 (4): 853–69PubMed

28.

Smith AM, Milliner EK. Injured athletes and the risk of suicide. J Athl Train 1987; 29: 337–41

29.

Smith AM, Scott SG, Wiese DM. The psychological effects of sports injuries: coping. Sports Med 1990; 9: 353–69

30.

Begel D. The psychopathology of everyday athletic life. In: Begel D, Burton RW, editors. Sport psychiatry. New York (NY): WW Norton & Company, Inc., 2000: 82–92

31.

Kamm RL. Interviewing principles for the psychiatrically aware sports medicine physician. Clin Sports Med 2005; 24 (4): 745–69PubMed

32.

Northon PJ, Burns JA, Hope DA. Generalization of social anxiety to sporting and athletic situations: gender, sportsinvolvement, and parental pressure. Depress Anxiety 2000; 12: 193–202

33.

Glasser W. Positive addiction. New York (NY): Harper and Row, 1976

34.

Sachs ML, Pargman D. Running addiction: a depth interview examination. J Sport Behav 1979; 2: 143–55

35.

Yates A, Leehey K, Shisslak CM. Running: an analogue of anorexia? N Engl J Med 1983; 308 (5): 251–5PubMed

36.

Pope H, Gruber A, Choi P, et al. Muscle dysmorphia: an underrecognized form of body dysmorphic disorder. Psychosomatics 1997; 38: 548–57PubMed

37.

Calhoun JW, Ogilvie BC, Hendrickson TP, et al. The psychiatric consultant in professional team sports. Child Adolesc Psychiatr Clin N Am 1998; 7 (4): 791–802PubMed

38.

Rosen LW, McKeag DB, Hough DO, et al. Pathogenic weight-control behavior in female athletes. Phys Sportsmed 1986; 14 (1): 79–86

39.

Burckes-Miller ME, Black DR. Behaviors and attitudes associated with eating disorders: perceptions of collegeathletes about food and weight. Health Educ Res 1988; 3: 203–8

40.

Byrne S, McLean N. Elite athletes: effects of the pressure to be thin. J Sci Med Sport 2002; 5: 80–94PubMed

41.

Torstveit MK, Rosenvinge JH, Sundgot-Borgen J. Prevalence of eating disorders and the predictive power ofrisk models in female elite athletes: a controlled study. Scand J Med Sci Sports 2008; 18: 108–18PubMed

42.

Sundgot-Borgen J, Torstveit MK. Prevalence of eating disorders in elite athletes is higher than in the generalpopulation. Clin J Sport Med 2004; 14: 25–32PubMed

43.

Thiel A, Gottfried H, Hesse FW. Subclinical eating disorders in male athletes: a study of the low weight categoryin rowers and wrestlers. Acta Psychiat Scand 1993; 88: 259–65PubMed

44.

Glazer JL. Eating disorders among male athletes. Curr Sports Med Rep 2008; 7 (6): 332–7PubMed

45.

Swoop RA, Murphy SM. Eating disorders and weight management in athletes. In: Murphy SM, editor. Sport psychology interventions. Champaign (IL): Human Kinetics, 1995: 307–26

46.

Johnson LD, O’Malley PM, Bachman JG, et al. Monitoring the future national survey on drug use, 1975–2003, Vol. II. College students and adults ages 19-25. NIH publication no. 04-5508. Bethesda (MD): National Instituteon Drug Abuse, 2004

47.

Green GA, Uryasz FD, Petr TA, et al. NCAA study of substance abuse habits of college student-athletes. Clin JSport Med 2001; 11 (1): 51–6

48.

O’Brien CP. Alcohol and sport: impact of social drinking on recreational and competitive sports performance. Sports Med 1993; 15: 71–7PubMed

49.

Miller BE, Miller MN, Verhegge R, et al. Alcohol misuse among college athletes: self-medication for psychiatric symptoms? J Drug Education 2002; 32 (1): 41–52

50.

McDuff DR, Baron D. Substance use in athletics: a sports psychiatry perspective. Clin Sports Med 2005; 24: 885–97PubMed

51.

Su TP, Pagliaro M, Schmidt PJ, et al. Neuropsychiatric effects of anabolic steroids in male normal volunteers. JAMA 1993; 269: 2760–4PubMed

52.

Moss HB, Panzak GL. Steroid use and aggression [letter]. Am J Psychiatry 1992; 149: 1616PubMed

53.

Pope HG, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use: a controlled study of 160athletes. Arch Gen Psychiatry 1994; 51: 375–82PubMed

54.

Kerber CS. Problem and pathological gambling among college athletes. Ann Clin Psychiatry 2005; 17 (4): 243–7PubMed

55.

Lesieur HR, Rosenthal RJ. Pathological gambling: a review of the literature (prepared for the American Psychiatric Association Task Force on DSM-IV. Committeeon Disorders of Impulse Control Not Elsewhere Classified). J Gambling Stud 1991; 7: 5–39

56.

Miller TW, Adams JM, Kraus RF, et al. Gambling as an addictive disorder among athletes: clinical issues in sportsmedicine. Sports Med 2001; 31 (3): 145–52PubMed

57.

Cantu RC. Prevention of athletic injuries: the role of the sports medicine team. In: Mueller FO, Ryan AJ, editors. Head and neck injuries. Philadelphia (PA): FA Davis, 1991: 201–13

58.

Broshek DK, Barth JT. Neuropsychological assessment of the amateur athletes. In: Bailes J, Day A, editors. Neurological sports medicine: a guide for physicians andathletic trainers. Rolling Meadows (IL): The AmericanAssociation of Neurological Surgeons, 2001: 155–68

59.

Freeman JR, Barth JT, Broshek DK. Sports injuries. In: Silver JM, McAllister TW, Yudofsky SC, editors. Textbookof traumatic brain injury. Washington, DC: American Psychiatric Publishing, 2001: 453–76

60.

Broshek DK, Kaushik T, Freeman JR. Gender differences in outcome from sports-related concussion. J Neurosurg 2005; 102: 856–63PubMed

61.

World Anti-Doping Agency [online]. Available from URL: http://www.wada-ama.org/en/ [Accessed 2009 Aug 13]

62.

Blomstrand E, Celsing F, Newsholme E. Changes in plasma levels of aromatic and branched chain amino acids duringsustained exercise in man and their possible role in fatigue. Acta Physiol Scand 1988; 133: 115–21PubMed

63.

Blomstrand E, Hassmen P, Ekblom B, et al. Administration of branched chain amino acids during sustainedexercise-effects on performance and on plasma concentrationof some amino acids. Eur J Appl Physiol 1991; 63: 83–8

64.

Blomstrand E, Hassmen P, Newsholme E. Effect of branched chain amino acid supplementation on mental performance. Acta Physiol Scand 1991; 143: 225–6PubMed

65.

Roelands B, Hasegawa H, Watson P, et al. The effects of acute dopamine reuptake inhibition on performance. Med Sci Sports Exercise 2008; 40 (5): 879–85

66.

Parise G, Bosman MJ, Boecker DR. Selective serotonin reuptake inhibitors: their effect on high-intensity exerciseperformance. Arch Phys Med Rehabil 2001; 82: 867–71PubMed

67.

Meeusen R, Piacentini MF, van Den Eynde S, et al. Exercise performance is not influenced by a 5-HT reuptakeinhibitor. Int J Sports Med 2001; 22: 329–36PubMed

68.

Wilson WM, Maughan RJ. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man:administration of paroxetine, a 5-HT re-uptake inhibitor,reduces the capacity to perform prolonged exercise. Exp Physiol 1992; 77: 921–4PubMed

69.

Strachan AT, Leiper JB, Maughan RJ. Paroxetine administration fails to influence human exercise capacity, perceivedeffort or hormone responses during prolonged exercise in awarm environment. Exp Physiol 2004; 89.6: 657–64PubMed

70.

Piacentini MF, Meeusen R, Buyse L, et al. Hormonal responses during prolonged exercise are influenced by a selectiveDA/NA reuptake inhibitor. Br J Sports Med 2004; 38: 129–33PubMed

71.

Watson P, Hasegawa H, Roelands B, et al. Acute dopamine/ noradrenaline reuptake inhibition enhances humanexercise performance in warm, but not temperate conditions. J Physiol 2005; 565.3: 873–83PubMed

72.

Roelands B, Hasegawa H, Watson P, et al. Performance and thermoregulatory effects of chronic bupropion administrationin the heat. Eur J Appl Physiol 2009; 105 (3): 493–8PubMed

73.

Piacentini MF, Meeusen R, Buyse L, et al. No effect of a noradrenergic reuptake inhibitor on performance intrained cyclists. Med Sci Sports Exercise 2002; 34 (7): 1189–93

74.

Roelands B, Goekint M, Heyman E, et al. Acute noradrenaline reuptake inhibition decreases performance innormal and high ambient temperature. J Appl Physiol 2008; 105 (1): 206–12PubMed

75.

Fowler NO, McCall D, Chou T-C, et al. Electrocardiographic changes and cardiac arrhythmias in patients receivingpsychotropic drugs. AmJ Cardiol 1976; 37: 223–30

76.

Waslick BD, Walsh BT, Greenhill LL, et al. Cardiovascular effects of desipramine in children and adultsduring exercise testing. J Am Acad Child Adolesc Psychiatry 1999; 38 (2): 179–86PubMed

77.

de Zwaan M. Exercise and antidepressant serum levels. Biol Psychiatry 1992; 32: 210–11PubMed

78.

Smith DF. The effect of exercise and pain-stress on the renal clearance of lithium, sodium, potassium, and creatininein the rat. Int Pharmacopsychiatry 1973; 8: 217–20PubMed

79.

Miller EB, Pain RW, Skripal PJ. Sweat lithium in manicdepression. Br J Psychiatry 1978; 133: 477–8PubMed

80.

Jefferson JW, Greist JH, Clagnaz PJ, et al. Effect of strenuous exercise on serum lithium level in man. Am J Psychiatry 1982; 139 (12): 1593–5PubMed

81.

Tilkian AG, Schroeder JS, Kao J, et al. Effect of lithium on cardiovascular performance: report on extended ambulatorymonitoring and exercise testing before and duringlithium therapy. Am J Cardiol 1976; 38: 701–8PubMed

82.

Cowan DA. Drug abuse. In: Harries M, Williams C, Stanish WD et al., editors. Oxford textbook of sports medicine. New York (NY): Oxford University Press, 1994: 314–29

83.

Wilmore JH. Exercise testing, training, and beta-adrenergic blockade. Phys Sportsmed 1988; 16: 45–50

84.

Schwenk TL. Psychoactive drugs and athletic performance. Phys Sportsmed 1997; 25 (1): 33–46

85.

Marvin G, Sharma A, Aston W, et al. The effects of buspirone on perceived exertion and time to fatigue in man. Exp Physiol 1997; 82: 1057–60PubMed

86.

Kennedy M. Drugs and Athletes: an update. Adverse Drug React Bull 1994; 169: 639–42

87.

Smith GM, Beecher HK. Amphetamine sulfate and athletic performance. I: objective effects. JAMA 1959; 170: 542–57

88.

Chandler JV, Blair SN. The effect of amphetamines on selected physiological components related to athletic success. Med Sci Sports Exerc 1980; 12 (1): 65–9PubMed

89.

Shaikin B. Baseball’s 2008 drug test results released in report. Los Angeles Times, 2009 Jan 10 [online]. Available from URL: http://articles.latimes.com/2009/jan/10/sports/sp-newswire10 [Accessed 2010 Sep 17]

90.

Hickey G, Fricker P. Attention deficit hyperactivity disorder, CNS stimulants, and sport. Sports Med 1999; 27 (1): 11–21PubMed

91.

Conant-Norville DO, Tofler I. Attention deficit/hyperactivity disorder and psychopharmacologic treatments in theathlete. Clin Sports Med 2005; 24 (4): 829–43PubMed

92.

Atkinson G, Drust B, Reilly T, et al. The relevance of melatonin to sports medicine and science. Sports Med 2003; 33 (11): 809–31PubMed

93.

Gonzalez-Alonso J, Teller C, Andersen SL, et al. Influence of body temperature on the development of fatigue duringprolonged exercise in the heat. J Appl Physiol 1999; 86: 1032–9PubMed

94.

Walters TJ, Ryan KL, Tate LM, et al. Exercise in the heat is limited by a critical internal temperature. J Appl Physiol 2000; 89: 799–806PubMed

95.

Reilly T, Atkinson G, Budgett R. Effect of low-dose temazepam on physiological variables and performance tests following a westerly flight across five time zones. IntJ Sports Med 2001; 22: 166–74

96.

Ito SU, Kanbayashi T, Takemura T, et al. Acute effects of zolpidem on daytime alertness, psychomotor and physicalperformance. Neurosci Res 2007; 59: 309–13PubMed

97.

Holmberg G. The effects of anxiolytics on CFF. Pharmacopsychiatry 1982; 15 Suppl.: 49–53

98.

Maddock RJ, Casson EJ, Lott LA, et al. Benzodiazepine effects on flicker sensitivity: role of stimulus frequencyand size. Prog Neuropsychopharmacol Biol Psychiatry 1993; 17: 955–70PubMed

99.

Mougin F, Bourdin H, Simon-Rigaud ML, et al. Hormonal responses to exercise after partial sleep deprivationand after a hypnotic drug-induced sleep. J Sports Sci 2001; 19: 89–97PubMed

100.

Tafti M, Besset A, Billiard M. Effects of zopiclone on subjective evaluation of sleep and daytime alertness and onpsychomotor and physical performance tests in athletes. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16: 55–63PubMed

101.

Grobler LA, Schwellnus MP, Trichard C, et al. Comparative effects of zopiclone and loprazolam on psychomotorand physical performance in active individuals. Clin JSport Med 2000; 10 (2): 123–8

102.

Paul MA, Gray G, Kenny G, et al. Impact of melatonin, zaleplon, zopiclone, and temazepam on psychomotor performance. Aviat Space Environ Med 2003; 74 (12): 1263–70PubMed

103.

Charles RB, Kirkham AJT, Guyatt AR, et al. Psychomotor, pulmonary and exercise responses to sleep medication. Br J Clin Pharmac 1987; 24: 191–7

Title: Sport Psychiatry
A Systematic Review of Diagnosis and Medical Treatment of Mental Illness in Athletes
Authors: Dr Claudia L. Reardon
Robert M. Factor
Publication date: 01-11-2010
Publisher: Springer International Publishing
Published in: Sports Medicine / Issue 11/2010
Print ISSN: 0112-1642
Electronic ISSN: 1179-2035
DOI: https://doi.org/10.2165/11536580-000000000-00000

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Sport Psychiatry

A Systematic Review of Diagnosis and Medical Treatment of Mental Illness in Athletes

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 11/2010

The Impact of Training Modalities on the Clinical Benefits of Exercise Intervention in Patients with Cardiovascular Disease Risk or Type 2 Diabetes Mellitus

Short-Term Recovery from Prolonged Exercise

Physical Fitness Profiles of Young Men

The Effect of Playing Surface on Injury Rate

Behaviour, the Key Factor for Sports Injury Prevention